Smithfield Trust’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-95
Closed -$20K 1062
2023
Q3
$20K Hold
95
﹤0.01% 684
2023
Q2
$18K Hold
95
﹤0.01% 714
2023
Q1
$19K Hold
95
﹤0.01% 678
2022
Q4
$12K Hold
95
﹤0.01% 749
2022
Q3
$13K Hold
95
﹤0.01% 729
2022
Q2
$17K Hold
95
﹤0.01% 709
2022
Q1
$14K Hold
95
﹤0.01% 784
2021
Q4
$15K Hold
95
﹤0.01% 770
2021
Q3
$16K Hold
95
﹤0.01% 757
2021
Q2
$15K Hold
95
﹤0.01% 755
2021
Q1
$13K Hold
95
﹤0.01% 789
2020
Q4
$17K Hold
95
﹤0.01% 707
2020
Q3
$19K Hold
95
﹤0.01% 641
2020
Q2
$16K Buy
+95
New +$14.2K ﹤0.01% 661
2018
Q1
Sell
-405
Closed -$22K 1112
2017
Q4
$22K Buy
+405
New +$23.7K ﹤0.01% 652

Other funds holding SGEN

Smithfield Trust's SGEN Position: Q4 2023 in Review

Smithfield Trust sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 95 shares — an estimated $20K sold.

Smithfield Trust first reported a position in SGEN in Q4 2017 and held it in 15 quarters. The position peaked at $22K in Q4 2017. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Smithfield Trust reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Smithfield Trust sold 95 Seagen Inc. Common Stock shares in Q4 2023, an estimated $20K.
  • Smithfield Trust first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 15 quarters.
  • Smithfield Trust's Seagen Inc. Common Stock position peaked at $22K in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Smithfield Trust's 13F filing for Q4 2023, filed 7 Feb 2024.